See how your reported results read as versioned evidence records — linked to experiments and limitations.Know what the science actually supports before you trust the answer.
Press Enter ↵ to review claims
Explore by Goal
"If you thought that science was certain - well, that is just an error on your part."
- Richard Feynman
Quick Explanation
Copied
Author Review (skeptical, evidence-anchored)
Based on the provided paper-level extracts, Qiang Ding appears to have published across multiple biomedical (and even non-biomedical) areas—ranging from Zika immune evasion to vaccine-platform vesicles, multiplex PCR primer design, and cancer/immune modulation—suggesting breadth, but also making it hard to infer a single coherent scientific “signature” without full CV context.
The strongest excerpted evidence includes mechanistic perturbation + functional readouts in vivo (e.g., Zika NS5–STAT2 antagonism) , , and .
Scope note: Your prompt provides paper-level excerpts for multiple DOIs and a separate OpenAlex-like block with metrics that appear to refer to multiple different people named “Qiang Ding”. I therefore treat any “global author metrics” as unverifiable from the provided evidence and focus on mechanistic strength inside the excerpted papers.
Visual synthesis: key quantitative evidence present in the provided extracts
These plots use only the numeric values explicitly included in your provided paper-extract text.
(1) eMigrasomes: osmolarity vs observed migrasome-like structures
Extracted from the provided eLife 2025 excerpt .
(2) Zika: in vivo group sizes in A129 model for NS5 L162G
Group sizes from the provided Zika NS5 excerpt .
(3) Silk gradient hydrogels: modulus range perpendicular to field (near endpoints)
Endpoint modulus values explicitly in the hydrogel extract .
What the excerpted body implies about scientific strength
1) Mechanistic “causal” attempts appear in some papers (strength signal)
Zika NS5–STAT2 antagonism: The excerpt explicitly describes residue-level mutagenesis, engineered substitutions that preserve replication while disrupting STAT2 degradation, and functional readouts spanning interferon signaling, infection restriction (STAT2-dependent), and in vivo attenuation/protection .
Toxoplasma PPKL: The excerpt includes conditional depletion (AID system), phenotypes in replication/morphology, and genetic complementation rescue, which is a key causal design feature .
Polymer/biomaterials: The hydrogel excerpt describes controllable gradient formation with multiple characterization modalities (mechanical, molecular structure proxies, microscopy), supporting stronger engineering-to-phenotype mapping than purely correlative claims .
2) Cross-field breadth is evident, but coherence is hard to assess from excerpts alone
The provided list includes virology/immune evasion , vaccine-vesicle engineering , and bioinformatics/in silico primer design .
From a review standpoint, breadth can be a strength (transfer of methods) or a risk (fragmentation / lack of deep follow-through). With only excerpts and without a complete publication record mapped to a single identity, any “coherence” conclusion would be speculative.
3) Potential bias/confounding risks explicitly present in the excerpts (epistemic humility)
Conflicts of interest / translational incentives: The eMigrasome excerpt includes explicit competing interests tied to patent ownership and a company role, which does not invalidate the data, but does require skepticism about framing, selective reporting, and how broadly benefits are emphasized .
Model-to-human generalization gaps: Multiple excerpts highlight reliance on specific animal models (e.g., IFN-competent vs IFN-deficient contexts for Zika; in vitro/ex vivo models for vaccine immunogenicity), which can be mechanistically informative but also can fail to predict human outcomes .
Mechanistic overreach risk: Some extracts acknowledge that proximity labeling captures “nearby” proteins rather than direct binding (TgPPKL case) .
In silico validation limitation: The primer-design paper explicitly reports in silico evaluation and states the lack of wet-lab experimental validation in the provided extract .
Paper-to-paper critical signals (based only on provided excerpted content)
No (computational design; causal wet-lab perturbations absent in extract)
In silico coverage + taxon specificity, BLAST/ePCR checks
In silico only; thresholds/manual tuning and input dataset dependence; limited experimental validation
Key blind spots in the provided “author” evidence
Identity ambiguity: The prompt’s OpenAlex-like block appears to match multiple “Qiang Ding” or similarly named individuals; without ORCID/affiliation disambiguation, author-level metrics and paper authorship attribution are uncertain.
Publication bias / selective excerpt risk: Your dataset includes strong mechanistic and high-impact claims, but doesn’t show failed replications, negative results, or null mechanistic tests. This can inflate perceived strength.
Reproducibility signals missing: Except for some explicit limitations (e.g., in silico-only validation), the extracts don’t consistently provide raw data depositions, independent lab replications, or cross-study benchmarking.
Translation and long-term endpoints: Several excerpts mention unknown long-term safety or limited in vivo diversity; these are important for “platform” claims (vaccine/immune evasion/vesicle systems).
What evidence would most disconfirm the implied strengths
For the Zika immune-evasion attenuation framework: show that L162 substitutions do not specifically disrupt ZSWIM8-CUL3 ubiquitination of STAT2, or that attenuation disappears in additional models/strains beyond those disclosed .
For eMigrasomes: demonstrate loss of RT stability, antigen presentation, or neutralizing efficacy, or show that the immunological protection does not generalize beyond the limited antigen set and small group sizes reported in the excerpt .
For TgPPKL essentiality: show that conditional depletion cannot be rescued genetically (or that rescue fails), or that phenotypes stem from degron-system artifacts rather than TgPPKL loss .
BGPT next-step (optional)
If you want, BGPT can automatically do an additional “strength ranking” across the provided set using the excerpt’s explicit causal/validation signals and produce an evidence-weighted comparison.
Feedback:
Updated: April 28, 2026
BGPT Author Review
Scientific Quality
50%
From the provided extracts, there are multiple moderate-to-strong mechanistic designs (notably genetic perturbation + functional readouts with rescue in TgPPKL and residue-level causal mapping in Zika). However, the evidence base is fragmented across very different domains (virology/vaccines/immunology/biomaterials/bioinformatics) and the author identity is ambiguous in the prompt. Several excerpts also rely on model systems with explicit translation limits, some studies are in silico only, and reproducibility/open raw-data signals are inconsistently provided. Overall: competent scientific execution in parts, but insufficient consistent identity-disambiguated track record to score higher.
Communication Quality
60%
The extracts are generally specific about methods and limitations, which suggests decent communication. But without the original paper text (figures, full statistical reporting, and author narrative), I can only judge from summarized excerpts; the prompt’s mixed domain set also makes it harder to evaluate clarity of a single throughline.
Author Novelty
50%
Several excerpts claim novelty (e.g., functional mapping of Zika NS5 residue permissiveness; engineering migrasome-like vesicles for RT-stable delivery; automated multiplex primer design via entropy/haplotype strategy). But without comparing against the full literature and without seeing whether these claims were independently validated, novelty can’t be scored very high from excerpts alone.
Scientific Rigor
50%
Rigor appears moderate-to-high in some causal mechanistic studies (genetic perturbation, rescue, multiple functional readouts). However, the overall excerpt set includes studies with limited in silico-only validation (primer design), small group sizes/short endpoints, reliance on proximity labeling, and explicit translation gaps. Missing consistent reproducibility/raw-data and independent replication signals reduces the rigor score.
None: your query is an author review, not a computational analysis task using provided sequences/tables.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
A proximity-labeled interactome of TgPPKL fully identifies its direct binding partners and substrate network without need for orthogonal biochemical validation—this is unlikely because the excerpt explicitly warns proximity ≠ direct interaction.
The entropy/haplotype conserved-region strategy in PMPrimer will universally produce multiplex primers with robust wet-lab performance regardless of input alignment quality and dataset composition—unlikely given the excerpt’s in silico-only validation limitation and dataset dependence.
Science Art
Science Movie
Make a narrated HD Science movie for this answer ($32 per minute)
Quick Explanation
Long Explanation
Top Data Sources
ExportMCP
Analysis Wizard
Hypothesis Graveyard
Discussion
Explore by Goal
Ask a Follow-Up
Key Insight
